| 中文名称 | (1S,3R)-甲基 1-(苯并[d][1,3]二氧戊环-5-基)-2,3,4,9-四氢-1H-吡啶并[3,4-b]吲哚-3-甲酸酯 |
|---|---|
| 中文别名 | (1S,3r)-甲基-1,2,3,4-四氢-1-(3,4-亚甲基二氧基苯基)-9h-吡啶并[3,4-b]吲哚-3-羧酸;舒托必利盐酸盐;他达那非中间体异构体杂质;(1S,3R)-甲基-1,2,3,4-四氢-1-(3,4-亚甲二氧苯基)-9H-吡啶并[3,4-b]吲哚-3-羧酸;他达拉非杂质VI |
| 英文名称 | (1S,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate |
| 英文别名 | (1S,3R)-Methyl-1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate;(1S,3R)-Methyl-1,2,3;methyl (1S,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate;Tadalafil Impuirty Ⅵ;(1S,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester;(1S,3R)-methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate? (Tadalafil Impurity;ZZ2W6KC4KM;DB-299479;InChI=1/C20H18N2O4/c1-24-20(23)15-9-13-12-4-2-3-5-14(12)21-19(13)18(22-15)11-6-7-16-17(8-11)26-10-25-16/h2-8,15,18,21-22H,9-10H2,1H3/t15-,18+/m1/s1;LIPVUDSNGRJSQE-QAPCUYQASA-;171596-42-2;1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-, methyl ester, (1S,3R)-;CS-0166262;NSC-809797;J-010740;methyl (1S,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3, 4-b]indole-3-carboxylate;(1S,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester;;SCHEMBL3847739;(1S,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate;NSC809797 |
| CAS号 | 171596-42-2 |
| 分子式 | C20H18N2O4 |
| 分子量 | 350.37 |
微信公众号
版权所有：济南迈纳科技有限公司 未经授权禁止拷贝本站资料，如有违反,将追究法律责任
备案号： 鲁ICP备2021031564号-1 危险品化学品经营许可证 营业执照
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
